Royce & Associates LP cut its stake in shares of Analogic Corporation (NASDAQ:ALOG) by 2.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 560,948 shares of the medical research company’s stock after selling 15,991 shares during the period. Royce & Associates LP owned about 4.50% of Analogic Corporation worth $40,753,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. American Century Companies Inc. increased its stake in Analogic Corporation by 43.3% in the second quarter. American Century Companies Inc. now owns 50,816 shares of the medical research company’s stock valued at $3,692,000 after buying an additional 15,364 shares during the period. BNP Paribas Arbitrage SA increased its stake in Analogic Corporation by 66.0% in the second quarter. BNP Paribas Arbitrage SA now owns 4,419 shares of the medical research company’s stock valued at $321,000 after buying an additional 1,757 shares during the period. Comerica Bank increased its stake in Analogic Corporation by 35.7% in the second quarter. Comerica Bank now owns 142,527 shares of the medical research company’s stock valued at $10,084,000 after buying an additional 37,501 shares during the period. Legal & General Group Plc increased its stake in Analogic Corporation by 7.7% in the second quarter. Legal & General Group Plc now owns 23,749 shares of the medical research company’s stock valued at $1,725,000 after buying an additional 1,696 shares during the period. Finally, SG Americas Securities LLC increased its stake in Analogic Corporation by 470.7% in the second quarter. SG Americas Securities LLC now owns 7,619 shares of the medical research company’s stock valued at $554,000 after buying an additional 6,284 shares during the period.

Analogic Corporation (NASDAQ ALOG) opened at 71.40 on Friday. Analogic Corporation has a one year low of $66.00 and a one year high of $95.85. The stock’s 50 day moving average is $70.56 and its 200-day moving average is $73.10. The firm’s market capitalization is $890.36 million.

Analogic Corporation (NASDAQ:ALOG) last announced its earnings results on Tuesday, June 6th. The medical research company reported $0.79 EPS for the quarter, topping the Zacks’ consensus estimate of $0.74 by $0.05. The business had revenue of $122.16 million during the quarter, compared to the consensus estimate of $121.35 million. Analogic Corporation had a negative net margin of 7.97% and a positive return on equity of 6.75%. The firm’s revenue was down 4.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.80 earnings per share. On average, analysts anticipate that Analogic Corporation will post $2.60 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Analogic Corporation (ALOG) Shares Sold by Royce & Associates LP” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another website, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The legal version of this news story can be read at https://www.thecerbatgem.com/2017/08/27/analogic-corporation-alog-shares-sold-by-royce-associates-lp.html.

Separately, Jefferies Group LLC assumed coverage on shares of Analogic Corporation in a research note on Wednesday, August 9th. They issued a “hold” rating and a $75.00 price target for the company. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $87.00.

About Analogic Corporation

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Want to see what other hedge funds are holding ALOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Analogic Corporation (NASDAQ:ALOG).

Institutional Ownership by Quarter for Analogic Corporation (NASDAQ:ALOG)

Receive News & Stock Ratings for Analogic Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Corporation and related stocks with our FREE daily email newsletter.